Yunnan Baiyao responded that it lost 1.5 billion in stock speculation: it will gradually optimize the structure and gradually withdraw from securities investment
Cailian news agency, October 28 (Xinhua) -- Yunnan Baiyao lost 1.5 billion in stock speculation and boarded the hot search list. On the same day, Yunnan Baiyao told reporters: "We have received criticism and correction from all parties. In fact, we have always adhered to our main business. As for securities investment, the main purpose of joining the board at that time was to improve the use efficiency of funds. In fact, our position has been reduced to this situation. At present, the company is very cautious about the investment target, and we will gradually optimize it in the future The investment structure will also gradually withdraw from securities investment. "
This text is a result of machine translation.
Related companies：
Briefing Aug 01, 2022 03:11 PM
· Healthcare
Biomedical Lab Supplies Producer Acumen Bags 100 Mn of CNY in Series A Round
In-depth
Healthcare
Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
Briefing Jun 28, 2022 04:29 PM
· Healthcare
Shuidi company has established a new pharmaceutical innovation division to further develop the pharmaceutical direction
Apr 18, 2022 06:30 PM
Apr 22, 2021 03:11 PM
Research
Consumer Staples, Technology, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Briefing May 18, 2022 04:45 PM
Taier shares: the contract dispute case against Cao Linbin was accepted by the court
In-depth
Healthcare
WIM 2022: Transcript of Fireside Chat of Biotech [1/2]
EqualOcean organized the WIM2022 event in New York City from July 29 to July 30, 2022. The following is the transcript for Fireside Chat of Biotech. Leon Tang, Bing Yuan, Ying Huang, Dahai Guo, and Sally Wang are the five guest speakers in this chat.
Aug 05, 2022 09:11 PM
Healthcare
Yunnan Baiyao's Revenue Rises 33%; Net Profit Falls 40% in 1Q 2021
On April 27, Yunnan Baiyao released a report for the first quarter of 2021 showing that the company's total operating revenue for the first quarter was 10.33 billion yuan, up 33.4% year-on-year; its operating profit was 880 million yuan, down 41.8% year-on-year; its net profit attributable to shareholders of the listed company was 760 million yuan.
Apr 30, 2021 02:07 AM
In-depth
Healthcare
Yunnan Baiyao: An Oriental Mystery in the Limelight (2/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:30 PM
In-depth
Healthcare
Yunnan Baiyao: An Oriental Mystery in the Limelight (1/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:00 PM
Briefing Oct 30, 2021 07:57 AM
· Healthcare
Economic Daily: enterprise investment should not abandon the main business
Briefing Oct 27, 2021 04:38 PM
· Healthcare
Wanyi Technology: the net profit in the first three quarters increased by 286.04% to 5.2454 million yuan
Briefing Aug 30, 2021 08:46 AM
· Healthcare
August 30 stock market lightning rod
Briefing Jul 07, 2021 03:24 PM
· Healthcare
The first bank of China fund to release its second Quarterly Report
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth
Insight
In-depth
Technology
WIM2022: Transcripts of Blockchain Panel, Brilliant Future With Opportunities
Aug 05, 2022 02:06 AM